Clinical Trials
126 trialsABC
University of California, San Francisco
BIOSUNTOX
University Hospital, Rouen
ABLE-41
Ferring Pharmaceuticals
uPARCRPC
Rigshospitalet, Denmark
DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine
Mayo Clinic
ALU
Hopital Foch
GENTleMEN
University of Washington
Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
Medical Diagnostic Laboratories, LLC
Contemporary Characteristics of Penile Cancer
M.D. Anderson Cancer Center
RI-NIVO
Azienda USL Reggio Emilia - IRCCS
Collection of Blood in Studying Metabolites in Patients With Prostate Cancer
University of Southern California
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Indiana University
PEAR-TREE2
Ourotech, Inc.
Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations
Telix Pharmaceuticals (Innovations) Pty Limited
Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy
National Institutes of Health Clinical Center (CC)
Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
National Institutes of Health Clinical Center (CC)
URADJ
Bristol-Myers Squibb
Genetic Evaluation of Men (GEM)
Thomas Jefferson University
Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment
Thomas Jefferson University
Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
Mayo Clinic
ES-HIFU
EDAP TMS S.A.
WB-LuPSMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Biomarker Identification for Bladder Cancer Patients
Ohio State University Comprehensive Cancer Center
Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals
Swiss Paraplegic Research, Nottwil
Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).
Pfizer
PSMA-PET/CT Registry
AHS Cancer Control Alberta
pCHIP: Prostate Cancer Health Impact Program
Weill Medical College of Cornell University
Immune PDX
Duke University
OPTIMISE
Pfizer
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
University of Southern California
TRAVELER
Pfizer
PET-PSMA
Latin American Cooperative Oncology Group
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy
University of Vermont
TRACE
Boston Scientific Corporation
Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
Vanderbilt University Medical Center
CREDIT
Bayer
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
Fate Therapeutics
CHARTER
Angle plc
A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer
Pfizer
In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies
Clinica Luganese Moncucco
CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib
xCures
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
University of Southern California
An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital
University of California, San Francisco
Initiative to Minimize Disparities in Postoperative Prostate Cancer Care
Albert Einstein Healthcare Network
Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer
Myriad Genetic Laboratories, Inc.
Transrectal Photoacoustic Imaging of the Prostate
Stanford University
P-PROVE
Myriad Genetic Laboratories, Inc.
LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer
Wake Forest University Health Sciences
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting
Exosome Diagnostics, Inc.